DNA aptamer-based sensors can accurately detect trace amounts of fentanyl, heroin, and cocaine

FHS
March 5, 2024
6:42 pm

Researchers from North Carolina State University have developed a new generation of high-performance DNA aptamers and highly accurate drug sensors for cocaine and other opioids.

With new Wegovy data in hand, Novo Nordisk will file for approval in MASH

Novo Nordisk’s weight loss drug Wegovy helped people with a fatty liver disease called MASH experience improvements in liver scarring and achieve symptom resolution, results

November 1, 2024

Ounce Raises $5.2M to Bridge the Gap Between Housing and Health

What You Should Know: – Ounce, a company bridging the gap between health and housing has raised a $5.2M seed round co-led by Meridian Street

October 5, 2023

Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq Form 6 K | Psychedelic Invest

NEW YORK, November 12, 2024 — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced the voting results for each of the

November 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.